Published in Thromb Haemost on April 01, 2002
Neutrophil granulocyte-dependent proteolysis enhances platelet adhesion to the arterial wall under high-shear flow. J Thromb Haemost (2010) 0.92
Management of antithrombotic therapy in patients undergoing invasive procedures. N Engl J Med (2013) 5.19
Association of heparin-dependent antibodies and adverse outcomes in hemodialysis patients: a population-based study. Mayo Clin Proc (2005) 2.17
Prognostic value of ankle-brachial index and dobutamine stress echocardiography for cardiovascular morbidity and all-cause mortality in patients with peripheral arterial disease. J Vasc Surg (2007) 2.06
Periprocedural anticoagulation management of patients with nonvalvular atrial fibrillation. Mayo Clin Proc (2008) 1.97
Profibrinolytic, antithrombotic, and antiinflammatory effects of an insulin-sensitizing strategy in patients in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial. Circulation (2011) 1.81
Ovarian vein thrombosis: incidence of recurrent venous thromboembolism and survival. Thromb Haemost (2006) 1.76
The United States Registry for Fibromuscular Dysplasia: results in the first 447 patients. Circulation (2012) 1.75
Health status after treatment for coronary artery disease and type 2 diabetes mellitus in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial. Circulation (2010) 1.56
A study of a weight-adjusted aprotinin dosing schedule during cardiac surgery. Anesth Analg (2002) 1.56
Factors contributing to individual propensity for arterial thrombosis. Arterioscler Thromb Vasc Biol (2002) 1.42
Comparison of PD0348292, a selective factor Xa inhibitor, to antiplatelet agents for the inhibition of arterial thrombosis. Thromb Haemost (2008) 1.39
Dabigatran: a primer for neurosurgeons. World Neurosurg (2012) 1.39
Long-term survival and amputation risk in thromboangiitis obliterans (Buerger's disease). J Am Coll Cardiol (2004) 1.22
Differences between human proteinase 3 and neutrophil elastase and their murine homologues are relevant for murine model experiments. FEBS Lett (2005) 1.15
Clinical characteristics and long-term follow-up of patients with renal vein thrombosis. Am J Kidney Dis (2008) 1.07
Acute venous disease: venous thrombosis and venous trauma. J Vasc Surg (2007) 1.06
Survival and recurrence in patients with splanchnic vein thromboses. Clin Gastroenterol Hepatol (2009) 1.04
Microwave and digital imaging technology reduce turnaround times for diagnostic electron microscopy. Ultrastruct Pathol (2003) 0.96
Warfarin or low-molecular-weight heparin therapy does not prolong pig-to-primate cardiac xenograft function. Am J Transplant (2005) 0.96
Predicting left atrial thrombi in atrial fibrillation. Am Heart J (2010) 0.94
Surgical pathology of hypothenar hammer syndrome with new pathogenetic insights: A 25-year institutional experience with clinical and pathologic review of 67 cases. Am J Surg Pathol (2013) 0.92
Effective antiplatelet therapy does not prolong transgenic pig to baboon cardiac xenograft survival. Xenotransplantation (2004) 0.92
Brain lesions in cerebral venous sinus thrombosis. Stroke (2009) 0.92
Periprocedural bridging management of anticoagulation. Circulation (2012) 0.90
Clinical manifestations of fibromuscular dysplasia vary by patient sex: a report of the United States registry for fibromuscular dysplasia. J Am Coll Cardiol (2013) 0.89
Failure of dabigatran and rivaroxaban to prevent thromboembolism in antiphospholipid syndrome: a case series of three patients. Thromb Haemost (2014) 0.87
Peri-procedural anticoagulation management of mechanical prosthetic heart valve patients. Thromb Res (2009) 0.87
Effects of carboxy-terminal modifications of proteinase 3 (PR3) on the recognition by PR3-ANCA. Kidney Int (2003) 0.85
Inhibition of platelet-rich arterial thrombus in vivo: acute antithrombotic effect of intravenous HMG-CoA reductase therapy. Arterioscler Thromb Vasc Biol (2009) 0.84
The "normal" factor VIII concentration in plasma. Thromb Res (2010) 0.82
Left atrial blood stasis and Von Willebrand factor-ADAMTS13 homeostasis in atrial fibrillation. Arterioscler Thromb Vasc Biol (2011) 0.82
Cardiomyopathy associated with celiac disease. Mayo Clin Proc (2005) 0.82
Patients with a history of type II heparin-induced thrombocytopenia with thrombosis requiring cardiac surgery with cardiopulmonary bypass: a prospective observational case series. Anesth Analg (2003) 0.81
The association of active cancer with venous thromboembolism location: a population-based study. Mayo Clin Proc (2011) 0.81
Functional significance of Asn-linked glycosylation of proteinase 3 for enzymatic activity, processing, targeting, and recognition by anti-neutrophil cytoplasmic antibodies. J Biochem (2006) 0.80
Outcomes of venoplasty with stent placement for chronic thrombosis of the iliac and femoral veins: single-center experience. J Vasc Interv Radiol (2012) 0.79
The role of novel anticoagulants in the management of venous thromboembolic disease. Curr Treat Options Cardiovasc Med (2014) 0.79
Lupus anticoagulant, warfarin, and alternative laboratory monitoring of anticoagulation. J Thromb Thrombolysis (2014) 0.79
Antithrombotic therapy and invasive procedures. N Engl J Med (2013) 0.79
Physical and enzymatic perturbation of the architecture of the Tunica media destroys its inherent thromboresistance. Thromb Haemost (2002) 0.79
Early subclinical coronary artery calcification in young adults who were pediatric kidney transplant recipients. Am J Transplant (2005) 0.78
Individual propensity for thrombosis: comparison of venous and arterial circulations. Thromb Res (2007) 0.78
Platelet activation and its patient-specific consequences. Thromb Res (2007) 0.78
Influence of anatomical location on arterial thrombosis. Arterioscler Thromb Vasc Biol (2002) 0.78
Variability of plasma aprotinin concentrations in pediatric patients undergoing cardiac surgery. J Thorac Cardiovasc Surg (2004) 0.78
Reasons for the persistent incidence of venous thromboembolism. Thromb Haemost (2016) 0.77
Immunohistochemistry of thrombi following iliac venous stenting: a novel model of venous thrombosis. Thromb Haemost (2006) 0.77
Platelet factor XIII gene expression and embolic propensity in atrial fibrillation. Thromb Haemost (2011) 0.77
Fibrin d-dimer concentration, deep vein thrombosis symptom duration, and venous thrombus volume. Angiology (2010) 0.77
Comparison of PFA-100 testing and bleeding time for detecting platelet hypofunction and von Willebrand disease in clinical practice. Thromb Haemost (2003) 0.77
A prospective, randomized platelet-function study of heparinized oxygenators and cardiotomy suction. J Cardiothorac Vasc Anesth (2006) 0.76
Correlation of point-of-care International Normalized Ratio to laboratory International Normalized Ratio in hemodialysis patients taking warfarin. Clin J Am Soc Nephrol (2008) 0.75
Three-month cumulative incidence of thromboembolism and bleeding after periprocedural anticoagulation management of arterial vascular bypass patients. J Thromb Thrombolysis (2013) 0.75
Health-related quality of life in children and young adults with post-thrombotic syndrome: results from a cross-sectional study. Pediatr Blood Cancer (2014) 0.75
Images in vascular medicine. Popliteal venous aneurysm. Vasc Med (2009) 0.75
Thrombophilia differences in splanchnic vein thrombosis and lower extremity deep venous thrombosis in North America. J Gastroenterol (2012) 0.75
Septic venous thromboembolism. Vasc Med (2012) 0.75
Images in vascular medicine. Fibromuscular dysplasia: an atypical cause of intermittent claudication. Vasc Med (2004) 0.75
Distribution of thromboembolism in valvular versus non-valvular atrial fibrillation. Expert Rev Cardiovasc Ther (2014) 0.75
Development and initial validation of a questionnaire to diagnose the presence and severity of post-thrombotic syndrome in children. Pediatr Blood Cancer (2011) 0.75
Ovarian Vein Thrombosis: Incidence of Recurrent Venous Thromboembolism and Survival. Obstet Gynecol (2017) 0.75
Clinical pearls in vascular medicine and anticoagulation. Dis Mon (2015) 0.75
Accuracy of capillary whole blood international normalized ratio on the CoaguChek S, CoaguChek XS, and i-STAT 1 point-of-care analyzers. Am J Clin Pathol (2008) 0.75
Dabigatran Versus Warfarin in Relation to Renal Function in Patients With Atrial Fibrillation. J Am Coll Cardiol (2016) 0.75
Portal venous thrombosis after distal pancreatectomy: clinical outcomes. J Gastrointest Surg (2014) 0.75
Outcomes and total costs of outpatient vs. inpatient peri-procedural anticoagulation management of mechanical prosthetic heart valve patients. Int J Cardiol (2013) 0.75
Periprocedural anticoagulant management. Hosp Pract (1995) (2012) 0.75
Natural language processor as a tool to assess heparin induced thrombocytopenia awareness. J Thromb Thrombolysis (2012) 0.75
Arteriovenous malformation culprit or innocent bystander? J Am Coll Cardiol (2009) 0.75